The COX-2 Gene and the Immune System
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01678222|
Recruitment Status : Completed
First Posted : September 3, 2012
Last Update Posted : March 21, 2018
- The immune system contains several different types of cells in the blood and other parts of the body. The body can fight infections well with the right balance of these cell types. The wrong balance of cell types may cause diseases, such as allergies or asthma. The COX-2 gene may help decide the balance of cell types that the body makes as part of the immune system. It may also play a role in certain immune system diseases. Researchers want to see how COX-2 affects the cells in the immune system.
- To study how the COX-2 gene works in the body s immune system.
- Individuals 18 years of age and above who are part of the Environmental Polymorphisms Registry.
- Participants will have one study visit at the National Institutes of Health. They will collect a urine sample at home on the morning of the study visit.
- Participants will have a physical exam and medical history. They will provide a blood sample. They will also give researchers the urine sample they collected that morning.
- No treatment will be provided as part of this study.
|Condition or disease|
|Cyclooxygenase-2 Lymphocyte Eicosanoid Prostaglandin|
|Study Type :||Observational|
|Actual Enrollment :||117 participants|
|Official Title:||The Role of Functionally Relevant Cyclooxygenase-2 (COX-2) Gene Single Nucleotide Polymorphisms -765G>C and 8473T>C in Lymphocyte Differentiation|
|Study Start Date :||August 27, 2012|
- To determine whether 765>C is associated with altered Th2, Th9, and Th17 differentiation in vivo
- To determine whether 8473T>C is associated with altered Th2, Th9, and Th17 differentiation in vivo
- To determine whether 765G>C is associated with altered prostaglandin and cytokine levels in vivo
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01678222
|United States, North Carolina|
|NIEHS Clinical Research Unit (CRU)|
|Research Triangle Park, North Carolina, United States|
|Principal Investigator:||Darryl C Zeldin, M.D.||National Institute of Environmental Health Sciences (NIEHS)|